FDA Issues Diabetes Device Warning After Serious Adverse Event By Steve Duffy Digital Content Editor Publish Date May 17, 2019
Promacta Oral Suspension Recalled Due to Possible Peanut Contamination By Diana Ernst, RPh Publish Date May 13, 2019
Glass Fragment Prompts Recall of Immunosuppressive Agent By Diana Ernst, RPh Publish Date May 2, 2019
Injectable Pain Med Recalled Due to Possible Microbial Contamination By Diana Ernst, RPh Publish Date May 1, 2019
FDA: Boxed Warning, Contraindication Added to Several Insomnia Medications By Diana Ernst, RPh Publish Date April 30, 2019
Fentanyl Transdermal Patches Recalled Due to Product Mislabeling By Diana Ernst, RPh Publish Date April 22, 2019
FDA Warns Against the Use of Unapproved Devices Marketed for Assessing Head Injury By Steve Duffy Digital Content Editor Publish Date April 11, 2019
FDA: Opioid Med Labels Will Include More Info on Appropriate Tapering in Physically Dependent Patients By Steve Duffy Digital Content Editor Publish Date April 10, 2019
FDA Warns Against the Use of Previously-Owned, Unauthorized Test Strips By Steve Duffy Digital Content Editor Publish Date April 9, 2019
FDA Cracks Down on Companies Selling E-Liquids Resembling Prescription Cough Meds By Diana Ernst, RPh Publish Date April 5, 2019
FDA: Warning Letters Sent to Several Homeopathic Product Manufacturers Due to Quality Issues By Steve Duffy Digital Content Editor Publish Date April 2, 2019
Levoleucovorin Injection Recalled Due to Presence of Particulate Matter By Steve Duffy Digital Content Editor Publish Date March 19, 2019
‘Potentially Concerning’ Signal Identified in Long-Term Follow-up Data Involving Paclitaxel-Coated Products By Steve Duffy Digital Content Editor Publish Date March 18, 2019
Oral Contraceptive Product Recalled Due to Packaging Error By Da Hee Han, PharmD Publish Date March 4, 2019
Increased Risk of Pulmonary Embolism, Death in RA Patients Reported in Tofacitinib Postmarketing Study By Diana Ernst, RPh Publish Date February 26, 2019
Uloric Labeling Updated With New Indication, Boxed Warning After Review of CV Safety Data By Diana Ernst, RPh Publish Date February 22, 2019
Antiepileptic Injectable Recalled Due to Product Mislabeling By Da Hee Han, PharmD Publish Date February 4, 2019
FDA: Unauthorized INR Test Strips Part of Large Recall By Steve Duffy Digital Content Editor Publish Date February 1, 2019
More Ibuprofen Oral Susp Lots Recalled Due to Higher Concentration By Da Hee Han, PharmD Publish Date January 30, 2019
FDA: Paclitaxel-Coated Devices for PAD Potentially Tied to Increased Mortality By Da Hee Han, PharmD Publish Date January 17, 2019
Glass Particulate Identified in Certain Vials of Vecuronium Bromide By Da Hee Han, PharmD Publish Date January 9, 2019
Antibiotic Recalled After Rubber Flecks Found in Reconstituted Vials By Da Hee Han, PharmD Publish Date January 7, 2019
Childrens’ Pain Reliever Recalled Due to Potentially Higher Potency Level By Da Hee Han, PharmD Publish Date December 6, 2018
Hypertension Combo Pill Recalled Due to Presence of Probable Carcinogen By Da Hee Han, PharmD Publish Date November 9, 2018
Oral Contraceptives Recalled Due to Incorrect Dispenser Instructions By Da Hee Han, PharmD Publish Date November 5, 2018
Another Antihypertensive Recalled Due to Potentially Carcinogenic Impurity By Diana Ernst, RPh Publish Date October 31, 2018
Second Impurity Identified in Recalled Valsartan Products By Steve Duffy Digital Content Editor Publish Date September 17, 2018
Four Homeopathic Products Recalled Due to Possible Microbial Contamination By Da Hee Han, PharmD Publish Date August 31, 2018
Asthma Medicine Recalled Due to Tablet Mix-Up That May Pose Safety Risk By Steve Duffy Digital Content Editor Publish Date August 31, 2018
Children’s Advil Suspension Recalled Due to Unmatched Dosage Cup By Da Hee Han, PharmD Publish Date August 28, 2018
FDA: Thyroid Medications Recalled Due to Inconsistent Potency By Da Hee Han, PharmD Publish Date August 20, 2018
Heart Meds Recalled After Discovery of Possible Carcinogenic Impurity By Diana Ernst, RPh Publish Date July 16, 2018
Blister Packs for Several Meds Recalled Due to Risk of Harm to Children By Da Hee Han, PharmD Publish Date July 9, 2018
Drug Used for Reversal of Neuromuscular Block Recalled Due to Mislabeling By Da Hee Han, PharmD Publish Date July 2, 2018
Oral Contraceptive Taytulla Recalled Due to Packaging Error By Da Hee Han, PharmD Publish Date May 29, 2018
Homeopathic Products for Teething, Nausea, Colic, Cough Recalled By Da Hee Han, PharmD Publish Date May 18, 2018
IV Combo Antibiotic Recalled Due to Potential for Decreased Potency By Da Hee Han, PharmD Publish Date May 15, 2018
Certain Lots of Kcentra Recalled Due to Potential Risk of Vial Breakage By Steve Duffy Digital Content Editor Publish Date April 6, 2018
Medical Food Used for Managing Osteoarthritis Recalled at FDA’s Request By Da Hee Han, PharmD Publish Date January 29, 2018
Injectable Antibiotic Combo Recalled Due to Glass Particles By Da Hee Han, PharmD Publish Date January 4, 2018
Diarrhea Med Recalled Due to Potential for Super or Sub Potent Tablets By Diana Ernst, RPh Publish Date November 17, 2017
Antiarrhythmic Agent Recalled Due to Presence of Particulate Matter By Da Hee Han, PharmD Publish Date November 16, 2017
‘Death Wish’ Coffee Recalled Due to Deadly Toxin Risk By Steve Duffy Digital Content Editor Publish Date September 21, 2017
Over 1 Million ADHD Patches Recalled Due to Liner Defect By Da Hee Han, PharmD Publish Date September 12, 2017
ESA Agent Recalled Due to Presence of Particulate in Vials By Diana Ernst, RPh Publish Date August 22, 2017
Stool Softeners Recalled Due to Possible Contamination By Da Hee Han, PharmD Publish Date August 3, 2017
Nitroglycerin Products Recalled Due to Low Potency By Steve Duffy Digital Content Editor Publish Date June 16, 2017
Anticoagulant Recalled Due to Incorrect Tablet Strength in Bottle By Diana Ernst, RPh Publish Date June 8, 2017
Birth Control Pills Recalled Due to Out of Sequence Tablets By Da Hee Han, PharmD Publish Date May 30, 2017
Edex Recalled Due to Defect that May Impact Sterility By Da Hee Han, PharmD Publish Date February 27, 2017
Ibuprofen Lysine Inj Recalled Due to Particulate Presence By Da Hee Han, PharmD Publish Date February 9, 2017
Drug Patch Recalled Due to Incorrect Dosing Instructions By Da Hee Han, PharmD Publish Date February 6, 2017
Ulcerative Colitis Treatment Recalled By Steve Duffy Digital Content Editor Publish Date December 16, 2016
Birth Control Pills Recalled Due to Reduced Ethinyl Estradiol Levels By Da Hee Han, PharmD Publish Date October 4, 2016
Anticholinergic Agent Used for GI, Other Disorders Recalled By Da Hee Han, PharmD Publish Date September 15, 2016
Over 260,000 Continuous Glucose Monitoring System Receivers Recalled By Da Hee Han, PharmD Publish Date April 12, 2016
FDA: Stop Using Recalled Portable Emergency Oxygen Device By Da Hee Han, PharmD Publish Date April 1, 2016
OTC Cough/Cold Product Recalled Due to Mislabeling By Da Hee Han, PharmD Publish Date February 22, 2016
Osteoporosis Tabs Recalled Due to Unknown Impurity Levels By Da Hee Han, PharmD Publish Date February 17, 2016
Contaminated Suspending Agents Used for Compounding Recalled By Da Hee Han, PharmD Publish Date February 11, 2016
Recalled IV Solutions Found to Contain Cardboard, Dried Skin Fragments By Da Hee Han, PharmD Publish Date January 27, 2016
